Yüklüyor......
Targeting BRAF Mutant Colorectal Cancer: Progress in Combination Strategies
BRAF mutations in colorectal cancer portend a poor prognosis, with first-line treatment often involving triplet or quadruplet chemotherapy, and single agent targeted therapy with BRAF inhibitors failing to demonstrate clinical activity. Blockade of multiple critical nodes along the MAPK and other pa...
Kaydedildi:
| Yayımlandı: | Cancer Discov |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5458523/ https://ncbi.nlm.nih.gov/pubmed/28576843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0087 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|